COLINZ LABORATORIES LTD. Share Price

COLINZ LABORATORIES LTD. Share Price

BSE: 531210
|
Pharmaceuticals
₹ 79.80
-₹0.69 (-0.86%)
1D
Last updated 24 Jul, 2026, 15:26 IST

COLINZ LABORATORIES LTD. Share Price Today

As of 25 Jul 2026, COLINZ LABORATORIES LTD. share price is ₹79.80. The stock opened at ₹80.98, compared to its previous close of ₹80.49. During today's trading session, COLINZ LABORATORIES LTD. share price moved in the range of ₹76.47 to ₹80.98, with an average price of ₹78.72 for the day. Looking at its last 52-week, the stock has touched a low of ₹36.11 and a high of ₹87.91.

₹76.47
0.86% down today
₹80.98
1D LOW
1D HIGH

COLINZ LABORATORIES LTD. Returns Calculator

Circuit
L
H
₹76.47
₹84.51
52-week
L
H
₹36.11
₹87.91
Mkt Cap Cr
10.14
P/E
19.27
P/B
1.13
ROE
5.12%
D/E
0.04
ROCE
7.05%
Div. Yield
0.00%
EPS(TTM)
2.04
Turnover
0.60
EV/EBITDA
2.22
Net Margin
0.00%
Op. Margin
0.00%
ROA
3.99%
Quick Ratio
0.00
Curr. Ratio
4.63
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Colinz Labs outperforming all market indices
Step 3 of 5
Valuation
Fairly Valued
Colinz Labs appears to be fairly valued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,65,711.0036.735.0514.85%0.5518.72%18.850.91%0.5610.90
Divis Laboratories1,93,860.0061.369.4016.19%0.0021.00%9.430.50%0.5898.19
Torrent Pharmaceuticals1,92,687.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,12,593.0033.553.2711.27%0.0014.95%423.360.93%0.4443.52
Zydus Lifesciences1,11,082.0017.393.2319.69%0.3520.30%3.700.11%0.3935.38
Lupin1,09,553.0019.834.7127.01%0.0327.44%3.510.78%0.61129.18
Mankind Pharma1,05,607.001.050.1212.65%0.4212.97%5.050.05%0.5449.37
Dr. Reddy's Laboratories97,364.9030.582.5611.07%0.1812.54%377.960.69%0.4138.68
Aurobindo Pharma88,508.4025.272.349.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs84,727.3060.2610.1018.21%0.4016.70%97.210.12%0.6413.72

COLINZ LABORATORIES LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹6.53₹7.03₹7.15₹6.97
Other Income₹0.30₹0.28₹0.17₹0.17
Total Revenue₹6.83₹7.30₹7.33₹7.15
Total Expenses₹6.21₹6.65₹6.73₹6.66
Profit Before Tax₹0.62₹0.65₹0.60₹0.48
Tax₹0.12₹0.16₹0.14₹0.14
Profit After Tax₹0.50₹0.49₹0.46₹0.34
EPS - Basic₹1.97₹1.93₹1.82₹0.74
EPS - Diluted₹1.97₹1.93₹1.82₹0.74

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹0.62₹0.65₹0.60₹0.48
Income before WC changes₹0.50₹0.54₹0.63₹0.59
Change in Assets-₹1.73₹0.37₹0.06₹0.60
Change in Liabilities-₹0.02₹0.30-₹0.14-₹0.56
Change in WC-₹1.75₹0.67-₹0.07₹0.03
Cash flow from Operations-₹1.45₹1.03₹0.40₹0.47
Cash flow from Investing-₹0.23₹0.01₹0.01-₹0.03
Cash flow from Financing₹0.24₹0.23₹0.11₹0.09
Total Cash Flow-₹1.45₹1.27₹0.52₹0.52
Cash (Start of the year)₹7.00₹5.73₹5.21₹4.68
Cash (End of the year)₹5.55₹7.00₹5.73₹5.21

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹2.80₹2.62₹2.40₹2.55
Current Assets₹9.02₹8.74₹7.84₹7.38
Total Assets₹11.82₹11.36₹10.23₹9.93
Current Liabilities₹2.16₹2.18₹1.89₹1.98
Net Current Asset₹6.85₹6.55₹5.95₹5.40
Non-Current Liabilities₹0.18₹0.23₹0.21₹0.26
Equity Capital₹9.47₹8.95₹8.14₹7.69
Total Equity & Liabilities₹11.82₹11.36₹10.23₹9.93
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
60.25
Neutral
ATR (14)
5.65
Neutral
STOCH(9,6)
65.61
Neutral
STOCH RSI (14)
62.83
Neutral
ADX(9)
24.72
Bearish
UO(9)
54.58
Neutral
ROC(12)
20
Bullish
WillR(14)
-26.46
Neutral
Period
Simple value
Exponential vaue
5D
80.47
79.87
10D
78.63
78.53
20D
77.1
75.49
50D
64.13
67.24
100D
54.87
60.2

About COLINZ LABORATORIES LTD.

COLINZ LABORATORIES LTD. Share Price
ISIN
INE923C01011
Sector Market Cap
₹ 10.14 Cr

Colinz Laboratories Ltd. is an India-based company that is engaged in the manufacturing and marketing of pharmaceutical formulations, particularly in the gynecological sector. It is engaged in the manufacturing and marketing various allopathic, ayurvedic, and nutraceuticals pharmaceutical formulations in the dosage forms of tablets, capsules, liquid orals and ointments, among others. The company has specialized products for Gynecology, cardiology, gastroenterology, and others. Its oncology products include imitinib, erlotinib, letrozole, exemestane, bortezomib, fludarabine phosphate, and doxorubicin. Its Ayurvedic products include anti-diarrhoeals, anti-pyretics, anti-inflammatories, anti-spasmodics, cough syrups, appetite stimulating agents, and memory boosters. Its nutraceuticals products include spirulina tabs/caps, spirulina with vitamins & minerals, omega 3 fatty acid caps in softgel, codliver oil with vitamin caps in soft gel, collagen, and glucosamine & chondroitin tabs.

COLINZ LABORATORIES LTD. Financial Highlights

  • Revenue: COLINZ LABORATORIES LTD. reported revenue of ₹6.62 crore in FY26 vs ₹6.83 crore in FY25. It showed a decrease of 3.07% on a yearly basis.
  • Operating Profit: COLINZ LABORATORIES LTD. reported an operating profit of ₹0.69 crore in FY26 vs ₹0.62 crore in FY25. It showed an increase of 11.29% on a year-on-year basis.
  • Net Profit: COLINZ LABORATORIES LTD. reported a net profit of ₹0.51 crore in FY26 vs ₹0.50 crore in FY25. It showed an increase of 2.00% on a yearly basis.

COLINZ LABORATORIES LTD. Quarterly Result Highlights

  • COLINZ LABORATORIES LTD. reported revenue of ₹1.92 crore in Mar 2026, compared with ₹1.51 crore in Dec 2025, representing an increase of 27.15% on a quarter-on-quarter (QoQ) basis.
  • COLINZ LABORATORIES LTD. reported an operating profit of ₹0.22 crore in Mar 2026, compared with ₹0.13 crore in Dec 2025, representing an increase of 69.23% on a quarter-on-quarter (QoQ) basis.
  • COLINZ LABORATORIES LTD. reported a profit of ₹0.17 crore in Mar 2026, compared with ₹0.08 crore in Dec 2025, reflecting an increase of 112.50% on a QoQ basis.
  • The earnings per share (EPS) of COLINZ LABORATORIES LTD. stood at ₹1.97 during Mar 2026.
Know more
Promoters
50.60%
FII
0.00%
Other DII
0.00%
Retail and other
49.40%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
COLINZ LABORATORIES LTD. Share Price
COLINZ LABORATORIES LTD.
Pharmaceuticals
Add Stock
Add Another

FAQs on COLINZ LABORATORIES LTD. Share Price